Amylyx Pharmaceuticals (AMLX) Non-cash Items (2021 - 2026)

Amylyx Pharmaceuticals' Non-cash Items history runs 6 years deep, the most recent figure standing at $5.6 million for Q1 2026.

• In Q1 2026, Non-cash Items rose 36.06% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $5.6 million (up 36.06% YoY), while the FY2025 annual figure was $5.3 million, up 43.03% from the prior year.
• Non-cash Items was $5.6 million for Q1 2026 at Amylyx Pharmaceuticals, down from $43.0 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $201.8 million in Q4 2022 to a low of $1.4 million in Q2 2022.
• Historically, Non-cash Items has averaged $32.1 million across 5 years, with a median of $5.1 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Non-cash Items soared 7092.7% in 2023, then tumbled 96.28% in 2024.
• A 5-year view of Non-cash Items shows it stood at $201.8 million in 2022, then plunged by 86.3% to $27.6 million in 2023, then tumbled by 87.03% to $3.6 million in 2024, then jumped by 1098.86% to $43.0 million in 2025, then sank by 87.06% to $5.6 million in 2026.
• The last three Non-cash Items figures came in at $5.6 million (Q1 2026), $43.0 million (Q4 2025), and $52.6 million (Q3 2025), per Business Quant data.